DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 66 filers reported holding DERMA SCIENCES INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $53,000 | -54.7% | 17,074 | -33.6% | 0.00% | – |
Q4 2015 | $117,000 | +134.0% | 25,700 | +140.4% | 0.00% | – |
Q3 2015 | $50,000 | -82.5% | 10,690 | -73.3% | 0.00% | -100.0% |
Q2 2015 | $286,000 | -70.0% | 39,971 | -64.5% | 0.00% | -71.4% |
Q1 2015 | $954,000 | -4.3% | 112,696 | +5.2% | 0.01% | 0.0% |
Q4 2014 | $997,000 | +617.3% | 107,105 | +539.6% | 0.01% | +600.0% |
Q3 2014 | $139,000 | -59.4% | 16,746 | -43.4% | 0.00% | -66.7% |
Q2 2014 | $342,000 | -25.7% | 29,600 | -18.4% | 0.00% | -25.0% |
Q1 2014 | $460,000 | – | 36,278 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,185,632 | $11,038,000 | 5.31% |
DAFNA Capital Management LLC | 384,794 | $3,582,000 | 2.83% |
Consonance Capital Management LP | 1,632,627 | $15,200,000 | 1.96% |
Broadfin Capital, LLC | 3,713,754 | $34,576,000 | 1.50% |
ROANOKE ASSET MANAGEMENT CORP/ NY | 265,946 | $2,476,000 | 0.85% |
Senvest Management, LLC | 1,151,926 | $10,724,000 | 0.76% |
HealthCor Management, L.P. | 920,000 | $8,565,000 | 0.48% |
J. Goldman & Co LP | 365,000 | $3,398,000 | 0.40% |
Baker Brothers Advisors | 3,537,137 | $32,931,000 | 0.34% |
Perceptive Advisors | 313,583 | $2,919,000 | 0.24% |